Physician profile
Ashley E Davis
NPI 1134778624
$5,485.55
in general payments reported to CMS, 2019-2025
38 companies · $1,126 in 2025
The $1,126 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $574 · 2022: $842 · 2023: $1,310 · 2024: $1,634 · 2025: $1,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,070.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,042.24 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boston Scientific Corporation | $662.95 | 2023-2025 | Exalt Model D, Spyglass, Acquire |
| Abbvie INC. | $549.60 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $514.45 | 2021-2025 | |
| Dexcom, INC. | $490.13 | 2021-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $375.72 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $325.02 | 2021-2023 | |
| Astrazeneca Pharmaceuticals Lp | $210.27 | 2021-2023 | Farxiga |
| Exact Sciences Corporation | $184.98 | 2023-2025 | Cologuard Collection Kit |
| Radius Health, INC. | $166.99 | 2021-2025 | Tymlos |
| Madrigal Pharmaceuticals | $94.22 | 2025 | Rezdiffra |
| Medtronic, INC. | $79.95 | 2023-2025 | Inpen Smart Insulin Delivery System, Inceptiv |
| Corcept Therapeutics | $76.46 | 2024-2025 | Korlym |
| Glaxosmithkline, LLC. | $60.67 | 2023-2025 | Trelegy Ellipta, Shingrix |
| Esperion Therapeutics, INC. | $56.98 | 2023-2024 | Nexletol |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $53.82 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.05 | 2021-2023 | Synjardy, Tradjenta |
| Xeris Pharmaceuticals, INC. | $42.26 | 2025 | Keveyis, Gvoke Hypopen |
| Axsome Therapeutics, INC. | $41.64 | 2022-2025 | Sunosi |
| Tandem Diabetes Care, INC. | $39.85 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Neurocrine Biosciences, INC. | $34.40 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.24 | 2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $29.36 | 2024 | Entyvio |
| Horizon Therapeutics Plc | $28.87 | 2021 | |
| Phathom Pharmaceuticals, INC. | $22.71 | 2024 | Voquezna |
| Astellas Pharma US INC | $22.25 | 2024 | Veozah |
| Alexion Pharmaceuticals, INC. | $21.35 | 2023 | Strensiq |
| Ascendis Pharma Endocrinology INC | $21.15 | 2025 | Yorvipath |
| Ascensia Diabetes Care US INC. | $19.71 | 2025 | |
| Sequel Med Tech, LLC | $18.19 | 2025 | Twiist |
| Tolmar, INC. | $17.08 | 2024 | |
| Acella Pharmaceuticals, LLC | $16.41 | 2025 | NP Thyroid 60 |
| Beta Bionics, INC. | $16.08 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Cequr Corporation | $14.53 | 2024-2025 | Cequr Simplicity |
| Kyowa Kirin, INC. | $14.07 | 2024 | Crysvita |
| Merck Sharp & Dohme LLC | $14.02 | 2021 | |
| Amgen INC. | $13.83 | 2025 | Tepezza |
| Janssen Pharmaceuticals, INC | $13.05 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.